Early glaucoma development post congenital cataract surgery

Article

Vigilance is required particularly in early infancy

"It is not yet clear if we can do anything to prevent the development of glaucoma in paediatric patients following congenital cataract surgery," declared Dr Allen Beck (glaucoma specialist at Emory University, Atlanta, Georgia, USA) when discussing the first year results of the study examining glaucomarelated adverse events in patients of the Infant Aphakia Treatment Study (IATS).1

Background

"IATS is a prospective, randomized study comprising two surgical approaches with congenital cataract surgery - no intraocular lens (IOL) and subsequent contact lens correction versus an IOL placed at the time of surgery," explained Dr Beck. "A protocol for these two approaches was followed for the randomized patients."

Standardized definitions for glaucoma were created within the IATS to ensure consistency. "We established standard definitions for glaucoma and glaucoma suspect. Previous studies have used differing definitions, so it is hard to compare the rates of glaucoma," added Dr Beck. "I am working with an international paediatric glaucoma group to further refine definitions and classification of paediatric glaucoma."

In addition to standardized definitions, examinations under anaesthesia were used to confirm diagnosis of patients and a standard examination protocol was employed for additional evaluations by the investigator if suspected glaucoma was noted.

Results

It was found that current surgical procedures did not prevent early development of glaucoma post congenital cataract surgery either with or without lens implantation. "It is important to note, that this paper represents the one year results," stressed Dr Beck. "Some investigators had postulated that improvements in cataract surgery or that using an IOL would reduce the number of early cases of glaucoma. Unfortunately, that is not what we found."

The results were a moderate surprise to the team. "The 1 year results showed more complications in the IOL group but no statistically significant difference on visual outcomes (again the 5 year results will be very important)," Dr Beck said. "Patient age still appears to play a role in the development of glaucoma. IATS investigators operated at a slightly older age (optimally 4–6 weeks, but a number of patients were older than that) in an effort to reduce early glaucoma cases, yet younger patient age was still a risk factor for the development of glaucoma." These odds decreased by 1.6 times every month the child aged.

It was also demonstrated that the chances of a child, with persistent foetal vasculature, developing a glaucoma-related adverse event was 3.1 times higher than those without persistent foetal vasculature.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.